Ó£ÌÒÊÓƵ

Ó£ÌÒÊÓƵ wins Biotech Company of the Year at the Cambridge Independent Science andTechnology awards.

SynbioBeta CEO John Cumbers talks reimagining cell therapies through cell reprogramming with Rick Klausner and Ó£ÌÒÊÓƵ CEO.

Dr Farah Patell-Socha, VP of Research Products discusses the launch of ioSkeletal Myocytes.

IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.

Ó£ÌÒÊÓƵ and the London Institute of Mathematical Sciences (LIMS) want to recreate every human cell type.

Ó£ÌÒÊÓƵ receives £40m of backing for technology that it claims can reliably reprogram stem cells.

Mark Kotter Bit Bio ideaSpace, focus on a founder, celebrating 10 years of idea space.

The investors behind Bit Bio's series A fundraise.